WuXi Biologics (Cayman) Inc. (WXXWY)
USD 4.3
(-1.15%)
USD 4.3
(-1.15%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 4.56 Billion CNY | 3.16% |
| 2022 | 4.42 Billion CNY | 2.94% |
| 2021 | 4.29 Billion CNY | 28.91% |
| 2020 | 3.33 Billion CNY | 51.87% |
| 2019 | 2.19 Billion CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | -100.0% |
| 2016 | 1.12 Billion CNY | 147.76% |
| 2015 | 455.85 Million CNY | 722.7% |
| 2014 | 55.41 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 2.15 Billion CNY | 0.0% |
| 2023 Q4 | 4.56 Billion CNY | 0.0% |
| 2023 FY | 4.56 Billion CNY | 3.16% |
| 2023 Q2 | 5.14 Billion CNY | 0.0% |
| 2022 Q2 | 4.39 Billion CNY | 0.0% |
| 2022 Q4 | 4.42 Billion CNY | 0.0% |
| 2022 FY | 4.42 Billion CNY | 2.94% |
| 2021 FY | 4.29 Billion CNY | 28.91% |
| 2021 Q4 | 4.29 Billion CNY | 0.0% |
| 2021 Q2 | 4.59 Billion CNY | 0.0% |
| 2020 Q2 | 3.68 Billion CNY | 0.0% |
| 2020 FY | 3.33 Billion CNY | 51.87% |
| 2020 Q4 | 3.33 Billion CNY | 0.0% |
| 2019 Q4 | 2.19 Billion CNY | 0.0% |
| 2019 FY | 2.19 Billion CNY | 0.0% |
| 2019 Q2 | 248.05 Million CNY | 0.0% |
| 2018 Q4 | - CNY | 0.0% |
| 2018 Q2 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 Q2 | 1.24 Billion CNY | 0.0% |
| 2017 Q4 | - CNY | 0.0% |
| 2017 FY | - CNY | -100.0% |
| 2016 Q4 | 1.12 Billion CNY | 0.0% |
| 2016 FY | 1.12 Billion CNY | 147.76% |
| 2015 Q2 | 113.96 Million CNY | 0.0% |
| 2015 Q1 | 113.96 Million CNY | 722.7% |
| 2015 Q4 | 113.96 Million CNY | 0.0% |
| 2015 FY | 455.85 Million CNY | 722.7% |
| 2015 Q3 | 113.96 Million CNY | 0.0% |
| 2014 Q3 | 13.85 Million CNY | 0.0% |
| 2014 Q4 | 13.85 Million CNY | 0.0% |
| 2014 FY | 55.41 Million CNY | 0.0% |
| 2014 Q1 | 13.85 Million CNY | 0.0% |
| 2014 Q2 | 13.85 Million CNY | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Eiger BioPharmaceuticals, Inc. | 41.2 Million USD | -10970.454% |
| Nanobac Pharmaceuticals, Incorporated | 4.12 Million USD | -110560.034% |
| SQZ Biotechnologies Company | 27.47 Million USD | -16504.27% |
| Evofem Biosciences, Inc. | 43.37 Million USD | -10416.586% |
| Santhera Pharmaceuticals Holding AG | 29.76 Million USD | -15223.471% |
| Mesoblast Limited | 118.7 Million USD | -3742.749% |
| Propanc Biopharma, Inc. | 948.27 Thousand USD | -480918.506% |
| Genus plc | 233.1 Million USD | -1856.825% |
| VioQuest Pharmaceuticals, Inc. | 2.93 Million USD | -155557.169% |
| CNBX Pharmaceuticals Inc. | 1.34 Million USD | -339391.911% |
| Marizyme, Inc. | 18.71 Million USD | -24269.496% |
| ContraFect Corporation | 2.88 Million USD | -158225.547% |
| Nymox Pharmaceutical Corporation | 750 Thousand USD | -608081.2% |
| PsyBio Therapeutics Corp. | 135.48 Thousand USD | -3366539.604% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.44 Million USD | -315277.106% |
| Intellipharmaceutics International Inc. | 2.32 Million USD | -196006.932% |
| AXIM Biotechnologies, Inc. | 5.65 Million USD | -80512.839% |
| MultiCell Technologies, Inc. | 202.58 USD | -2251633328.769% |
| Accustem Sciences Inc. | - USD | -Infinity% |
| RVL Pharmaceuticals plc | 57.48 Million USD | -7834.316% |
| EV Biologics, Inc. | 1.49 Million USD | -305058.451% |
| Q BioMed Inc. | 4.1 Million USD | -110882.484% |
| Emmaus Life Sciences, Inc. | 33.1 Million USD | -13680.124% |
| Neon Bloom, Inc. | 630.07 Thousand USD | -723836.757% |
| Mosaic ImmunoEngineering Inc. | 1.22 Million USD | -371237.009% |
| Biomind Labs Inc. | 735.54 Thousand USD | -620035.764% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| Pharming Group N.V. | 171.54 Million USD | -2558.987% |
| Oncotelic Therapeutics, Inc. | 12.99 Million USD | -34995.489% |
| Skye Bioscience, Inc. | 4.61 Million USD | -98731.985% |
| Therapeutic Solutions International, Inc. | 888.06 Thousand USD | -513529.536% |
| THC Farmaceuticals, Inc. | 141.51 Thousand USD | -3223065.251% |
| Arch Therapeutics, Inc. | 5.87 Million USD | -77591.86% |
| IMV Inc. | 28.88 Million USD | -15692.048% |
| Acro Biomedical Co., Ltd. | 25.71 Thousand USD | -17735266.849% |
| Curative Biotechnology, Inc. | 2.25 Million USD | -201874.733% |
| GB Sciences, Inc. | 1.75 Million USD | -259170.213% |
| Alpha Cognition Inc. | 1.22 Million USD | -373667.917% |
| HST Global, Inc. | 98.31 Thousand USD | -4639246.413% |
| CSL Limited | 12.18 Billion USD | 62.56% |
| Halberd Corporation | 150 Thousand USD | -3040806.0% |
| Enzolytics Inc. | 996.33 Thousand USD | -457712.409% |
| Resverlogix Corp. | 6.49 Million USD | -70172.054% |
| Affymax, Inc. | - USD | -Infinity% |
| SYBLEU INC | 477.5 Thousand USD | -955158.429% |
| Nuo Therapeutics, Inc. | 255.59 Thousand USD | -1784525.106% |
| argenx SE | 20 Million USD | -22706.795% |
| MetaStat, Inc. | - USD | -Infinity% |
| Northwest Biotherapeutics, Inc. | 45.56 Million USD | -9911.763% |
| Enzon Pharmaceuticals, Inc. | - USD | -Infinity% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -168296.424% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | - USD | -Infinity% |
| AVAX Technologies, Inc. | - USD | -Infinity% |
| Zenith Capital Corp. | 10.22 Thousand USD | -44609767.971% |
| Genscript Biotech Corporation | 417.73 Million USD | -991.917% |
| Ember Therapeutics, Inc. | 200.61 Thousand USD | -2273576.576% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.39 Million USD | -190137.033% |
| WPD Pharmaceuticals Inc. | 229.29 Thousand USD | -1989231.897% |
| American Oriental Bioengineering, Inc. | 67.64 Million USD | -6643.298% |
| Provectus Biopharmaceuticals, Inc. | 3.02 Million USD | -150629.382% |
| Adynxx, Inc. | - USD | -Infinity% |
| Helix BioMedix, Inc. | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -1267965.664% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Capstone Therapeutics Corp. | 20.32 Million USD | -22338.799% |
| Cotinga Pharmaceuticals Inc. | 148.65 Thousand USD | -3068340.136% |
| BioStem Technologies, Inc. | 4.71 Million USD | -96715.013% |
| ONE Bio Corp. | 19.71 Million USD | -23036.465% |
| Reve Technologies, Inc. | 250.18 Thousand USD | -1823116.299% |
| Burzynski Research Institute, Inc. | - USD | -Infinity% |
| Wesana Health Holdings Inc. | 248.72 Thousand USD | -1833833.339% |
| Agentix Corp. | 50 Thousand USD | -9122618.0% |
| LadRx Corporation | 33.6 Thousand USD | -13572949.455% |
| Cell Source, Inc. | 9.25 Million USD | -49189.748% |
| ProtoKinetix, Incorporated | - USD | -Infinity% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -603091.599% |
| Regen BioPharma, Inc. | 756.2 Thousand USD | -603091.599% |
| NovAccess Global Inc. | 2.19 Million USD | -207245.81% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -64391.468% |
| Itoco Inc. | 228.37 Thousand USD | -1997193.51% |
| Rasna Therapeutics, Inc. | 210.97 Thousand USD | -2161937.682% |
| Pathfinder Cell Therapy, Inc. | 4.98 Million USD | -91438.411% |
| Kadimastem Ltd | 891.22 Thousand USD | -511707.218% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -1134992.784% |
| CytoDyn Inc. | 30.07 Million USD | -15066.109% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | - USD | -Infinity% |
| Mobile Lads Corp. | 484.28 Thousand USD | -941776.874% |
| NanoSphere Health Sciences Inc. | - USD | -Infinity% |
| Qrons Inc. | 351.84 Thousand USD | -1296304.119% |
| Alseres Pharmaceuticals, Inc. | 7.81 Million USD | -58229.697% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| Nascent Biotech, Inc. | 122.5 Thousand USD | -3723458.367% |
| Rebus Holdings, Inc. | 310 Thousand USD | -1471306.129% |
| ImmunoCellular Therapeutics, Ltd. | 4.73 Million USD | -96227.083% |
| International Stem Cell Corporation | 4.17 Million USD | -109075.658% |
| Bioxytran, Inc. | 1.92 Million USD | -236853.714% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -7308247.62% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -209050.305% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 8.31 Million USD | -54750.397% |
| Adhera Therapeutics, Inc. | 8.58 Million USD | -53031.73% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 1.55 Million USD | -293144.653% |
| Innovation Pharmaceuticals Inc. | 268 Thousand USD | -1701899.627% |
| Neutra Corp. | 54.15 Thousand USD | -8422529.072% |
| Windtree Therapeutics, Inc. | 1.83 Million USD | -249154.59% |
| PureTech Health plc | 25.51 Million USD | -17779.269% |
| Coeptis Therapeutics, Inc. | 1.22 Million USD | -372491.254% |
| IXICO plc | 472.02 Thousand USD | -966242.53% |
| IntelGenx Technologies Corp. | 15.5 Million USD | -29326.224% |
| Gelesis Holdings, Inc. | 62.26 Million USD | -7225.954% |
| CSL Limited | 12.18 Billion USD | 62.56% |
| Cellectis S.A. | 92.77 Million USD | -4816.502% |